BMED Stock Overview
Provides various banking products and services in Italy. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Banca Mediolanum S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €11.04 |
| 52 Week High | €11.86 |
| 52 Week Low | €8.12 |
| Beta | 1.27 |
| 11 Month Change | -2.99% |
| 3 Month Change | 2.60% |
| 1 Year Change | 34.47% |
| 33 Year Change | 31.43% |
| 5 Year Change | 20.85% |
| Change since IPO | 50.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| BMED | AT Diversified Financial | AT Market | |
|---|---|---|---|
| 7D | -2.1% | 1.6% | -0.1% |
| 1Y | 34.5% | 15.3% | 2.9% |
Return vs Industry: BMED exceeded the Austrian Diversified Financial industry which returned 14.2% over the past year.
Return vs Market: BMED exceeded the Austrian Market which returned 2.5% over the past year.
Price Volatility
| BMED volatility | |
|---|---|
| BMED Average Weekly Movement | 2.3% |
| Diversified Financial Industry Average Movement | 3.9% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in AT Market | 6.5% |
| 10% least volatile stocks in AT Market | 1.8% |
Stable Share Price: BMED has not had significant price volatility in the past 3 months compared to the Austrian market.
Volatility Over Time: BMED's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 3,799 | Massimo Doris | www.bancamediolanum.it |
Banca Mediolanum S.p.A. provides various banking products and services in Italy. The company offers current accounts; deposits; and mortgages and loans. It also provides debit, credit, and prepaid cards; investment products, such as mutual funds, unit linked policies, investment strategies, other investments, trading, and retirement products; and life insurance products and services.
Banca Mediolanum S.p.A. Fundamentals Summary
| BMED fundamental statistics | |
|---|---|
| Market cap | €8.16b |
| Earnings (TTM) | €924.04m |
| Revenue (TTM) | €2.09b |
8.8x
P/E Ratio3.9x
P/S RatioIs BMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BMED income statement (TTM) | |
|---|---|
| Revenue | €2.09b |
| Cost of Revenue | €4.84m |
| Gross Profit | €2.09b |
| Other Expenses | €1.16b |
| Earnings | €924.04m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.25 |
| Gross Margin | 99.77% |
| Net Profit Margin | 44.19% |
| Debt/Equity Ratio | 207.4% |
How did BMED perform over the long term?
See historical performance and comparison